Relex-SMILE treatment for leftover nearsightedness after cataract surgery
Part of Eyes & vision clinical trials.
This trial tests whether Relex-SMILE eye laser surgery can improve nearsightedness that remains after you’ve already had cataract surgery. It’s meant for people with a certain range of leftover nearsightedness, while excluding certain eye problems and prior eye procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have leftover nearsightedness after 6 months, between about -0.75 and -5.50 (diopters)
- Your main problem is that your vision is still not clear because of this leftover nearsightedness
- You do not have active abnormal problems in the front part of the eye (front eye structures)
- You have not had prior cornea or front-of-eye surgery
- You do not have glaucoma
- You do not have a history of eye inflammation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a treatment to improve vision in people who still have an ongoing focusing problem (residual nearsightedness or farsightedness) about 6 months after receiving a trifocal intraocular lens. It may help if your vision is still reduced despite having the lens implanted.
This study compares two types of laser eye surgery (SMILE and SMILE Xtra) to see which works better for treating nearsightedness. The goal is to help you see clearly without glasses or contacts.
This trial studies how well the SMILE laser procedure works to correct very high nearsightedness. It may help people with strong focusing power problems, as long as their eye measurements and cornea shape meet the study limits.
This trial compares two types of laser eye surgery (CLEAR and SMILE) to see which works better for nearsightedness and astigmatism. If you are eligible, it could help find the best option for your vision.
This trial compares two laser vision correction methods: SMILE surgery in one eye and LASIK surgery in the other eye. It is designed for people with mild to moderate nearsightedness and astigmatism to see which approach works better.
This trial tests if a newer laser machine (VISUMAX 800) works as well as the current standard (VISUMAX 500) for correcting nearsightedness. It may help decide if the newer technology offers better outcomes for patients.
Hear when a new Pseudophakia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.